These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12488597)

  • 1. Diversity of the Brain Dystrophin-Glycoprotein Complex.
    Culligan K; Ohlendieck K
    J Biomed Biotechnol; 2002; 2(1):31-36. PubMed ID: 12488597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of an X(p21.2;q28) chromosomal inversion in a Duchenne muscular dystrophy patient with mental retardation reveals a novel long non-coding gene on Xq28.
    Tran TH; Zhang Z; Yagi M; Lee T; Awano H; Nishida A; Okinaga T; Takeshima Y; Matsuo M
    J Hum Genet; 2013 Jan; 58(1):33-9. PubMed ID: 23223008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonsense readthrough therapy for Duchenne muscular dystrophy].
    Takeshima Y
    Rinsho Shinkeigaku; 2014; 54(12):1074-6. PubMed ID: 25672712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dystrophin, neurogenetics and mental retardation.
    Mehler MF
    Brain Res Brain Res Rev; 2000 Apr; 32(1):277-307. PubMed ID: 10751678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular Dystrophy Model.
    Potikanond S; Nimlamool W; Noordermeer J; Fradkin LG
    Adv Exp Med Biol; 2018; 1076():147-172. PubMed ID: 29951819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
    Takeshima Y
    Rinsho Byori; 2015 Oct; 63(10):1194-201. PubMed ID: 26897856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genotype-phenotype discordance in a Duchenne muscular dystrophy patient due to a novel mutation: insights into the shock absorber function of dystrophin].
    López-Hernández LB; van Heusden D; Soriano-Ursúa MA; Figuera-Villanueva L; Vázquez-Cárdenas NA; Canto P; Gómez-Díaz B; Coral-Vázquez RM
    Rev Neurol; 2011 Jun; 52(12):720-4. PubMed ID: 21594857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
    Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
    Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy.
    Matsumura K; Tomé FM; Collin H; Azibi K; Chaouch M; Kaplan JC; Fardeau M; Campbell KP
    Nature; 1992 Sep; 359(6393):320-2. PubMed ID: 1406935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of the dystrophin-associated glycoprotein complex at the synapse.
    Pilgram GS; Potikanond S; Baines RA; Fradkin LG; Noordermeer JN
    Mol Neurobiol; 2010 Feb; 41(1):1-21. PubMed ID: 19899002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophin immunoreactivity in normal and Duchenne human fetal neurons in culture.
    Torelli S; Sogos V; Ennas MG; Muntoni F; Clerk A; Strong PN; Gremo F
    J Neurosci Res; 1992 May; 32(1):116-25. PubMed ID: 1378503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise and muscular dystrophy: implications and analysis of effects on musculoskeletal and cardiovascular systems.
    Barnabei MS; Martindale JM; Townsend D; Metzger JM
    Compr Physiol; 2011 Jul; 1(3):1353-63. PubMed ID: 23733645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of duchenne muscular dystrophy.
    Tokarz SA; Duncan NM; Rash SM; Sadeghi A; Dewan AK; Pillers DA
    Mol Genet Metab; 1998 Dec; 65(4):272-81. PubMed ID: 9889014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.
    Kudoh H; Ikeda H; Kakitani M; Ueda A; Hayasaka M; Tomizuka K; Hanaoka K
    Biochem Biophys Res Commun; 2005 Mar; 328(2):507-16. PubMed ID: 15694376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy.
    Kreis R; Wingeier K; Vermathen P; Giger E; Joncourt F; Zwygart K; Kaufmann F; Boesch C; Steinlin M
    NMR Biomed; 2011 Apr; 24(3):253-62. PubMed ID: 21404337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
    Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
    Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.
    Ervasti JM; Ohlendieck K; Kahl SD; Gaver MG; Campbell KP
    Nature; 1990 May; 345(6273):315-9. PubMed ID: 2188135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular studies in Duchenne muscular dystrophy.
    Emery AE
    Prog Clin Biol Res; 1989; 306():15-28. PubMed ID: 2662210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.